The SELUTION™ SLR drug-coated balloon is Cordis’ next-generation solution for coronary interventions. Unlike traditional stents, the balloon delivers sirolimus, a proven, safe, and effective anti-proliferative drug, directly into the vessel wall during angioplasty and then leaves nothing behind.
Key Points:
Indication: Treatment of coronary artery disease, including in-stent restenosis and small vessel disease.
Mechanism: Combines the mechanical vessel dilation of angioplasty with sustained sirolimus drug release, reducing the risk of restenosis.
Differentiator: Unlike paclitaxel balloons, sirolimus offers a well-established safety and efficacy profile (validated in drug-eluting stents).
Design: Proprietary coating technology enables controlled drug uptake and retention, ensuring consistent therapeutic effect.
Benefit: Provides interventional cardiologists with a “leave-nothing-behind” strategy that maintains vessel integrity, reduces long-term complications, and supports optimal patient outcomes.
Minimum Requirements
Advanced Clinical/Science degree or professional credentials strongly recommended (NP, MD, PhD, PharmD, and/or scientific background/experience)
3-5 years of field-based MSL experience and/or 3-5 years of work experience in the medical device or pharmaceutical industry required
Other skills :
Travel: Ability to support 70% travel schedule (domestic and international)
Job Requirements
1- Serve as a strategic medical and scientific resource
2- Responsible for effective Podium and Publication strategies
3- Establish and maintain credible peer-to-peer scientific relationships with national/regional key opinion leaders (KOLs) and customers.
4 - Responsible for oversight and execution of educational and Research grant process
5 - Manage process to handle unsolicited information requests about off-label products or indications.